Home › Trial NCT03510208
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- Trial IDNCT03510208
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorStanford University
- Enrollment46
- Start date2018-05-16
- ConditionsMalignant Brain Neoplasm · Malignant Glioma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.